Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

AffaMed and VistaGen Start China Phase III Trial of Social Anxiety Therapy

publication date: Apr 12, 2022

Shanghai AffaMed and VistaGen, a South San Francisco company, have filed an IND to conduct a China Phase III trial of their partnered therapy for adults with acute social anxiety disorder (SAD). PH94B is an odorless, as-needed, fast-acting (15 minutes) neuroactive pherine nasal spray with a novel mechanism of action. PALISADE Global is designed to evaluate the efficacy, safety and tolerability of VistaGen’s PH94B in China and other ex-US markets. The two companies plan to expand the Phase III trial into Canada, Mexico and South Korea. More details....

Stock Symbol: (NSDQ: VTGN)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here